We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$817M
AUM Growth
-$36.2M
Cap. Flow
-$39.4M
Cap. Flow %
-4.82%
Top 10 Hldgs %
12.04%
Holding
1,060
New
418
Increased
118
Reduced
111
Closed
413

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$12.8M
2
CRM icon
Salesforce
CRM
+$9.18M
3
NKE icon
Nike
NKE
+$8.85M
4
DHR icon
Danaher
DHR
+$8.43M
5
AMZN icon
Amazon
AMZN
+$8.08M

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$17.9M
2
TSLA icon
Tesla
TSLA
+$16.6M
3
CVX icon
Chevron
CVX
+$15.3M
4
MDB icon
MongoDB
MDB
+$9.4M
5
FTNT icon
Fortinet
FTNT
+$8.82M

Sector Composition

Rank Sector Weight
1 Technology 22.57%
2 Consumer Discretionary 15.97%
3 Healthcare 14.57%
4 Industrials 11.33%
5 Financials 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LMND icon
376
Lemonade
LMND
$4.17B
$489K 0.06%
+13,329
New +$426K
NRDS icon
377
NerdWallet
NRDS
$620M
$482K 0.06%
+36,261
New +$484K
CPAY icon
378
Corpay
CPAY
$26.5B
$482K 0.06%
+1,424
New +$501K
AROC icon
379
Archrock
AROC
$5.62B
$480K 0.06%
+19,300
New +$447K
OS
380
DELISTED
OneStream Inc
OS
$479K 0.06%
+16,800
New +$515K
VLY icon
381
Valley National Bancorp
VLY
$7.71B
$477K 0.06%
+52,700
New +$511K
MTSI icon
382
MACOM Technology Solutions
MTSI
$21.2B
$475K 0.06%
+3,657
New +$460K
GSK icon
383
GSK
GSK
$101B
$475K 0.06%
+14,037
New +$505K
REVG
384
DELISTED
REV Group
REVG
$473K 0.06%
+14,837
New +$441K
RDN icon
385
Radian Group
RDN
$4.83B
$473K 0.06%
14,900
+7,500
+101% +$255K
HGV icon
386
Hilton Grand Vacations
HGV
$3.41B
$467K 0.06%
+12,000
New +$473K
CHRW icon
387
C.H. Robinson
CHRW
$17.7B
$465K 0.06%
4,500
+2,462
+121% +$265K
RAMP icon
388
LiveRamp
RAMP
$2.3B
$456K 0.06%
+15,001
New +$419K
TDC icon
389
Teradata
TDC
$2.66B
$455K 0.06%
+14,600
New +$457K
ATEC icon
390
Alphatec Holdings
ATEC
$1.48B
$454K 0.06%
+49,500
New +$395K
RXRX icon
391
Recursion Pharmaceuticals
RXRX
$1.84B
$452K 0.06%
+66,900
New +$450K
JANX icon
392
Janux Therapeutics
JANX
$1.15B
$444K 0.05%
+8,300
New +$439K
PRO
393
DELISTED
PROS Holdings
PRO
$444K 0.05%
+20,234
New +$435K
INGR icon
394
Ingredion
INGR
$6.53B
$440K 0.05%
+3,200
New +$450K
BTU icon
395
Peabody Energy
BTU
$3.59B
$440K 0.05%
+21,002
New +$519K
DESP
396
DELISTED
Despegar.com
DESP
$437K 0.05%
+22,700
New +$357K
TD icon
397
Toronto Dominion Bank
TD
$198B
$434K 0.05%
+8,145
New +$457K
AGYS icon
398
Agilysys
AGYS
$3.4B
$434K 0.05%
+3,292
New +$403K
DLO icon
399
dLocal
DLO
$4.46B
$432K 0.05%
38,400
-68,500
-64% -$690K
BUD icon
400
AB InBev
BUD
$156B
$431K 0.05%
8,600
-4,800
-36% -$278K
14 15
16
17 18

Similar funds

MCM
Mork Capital Management Healdsburg, California $156M AUM 39.85% 1-Year Est. Return
MFG
Mosaic Financial Group Chicago, Illinois $156M AUM 23.77% 1-Year Est. Return
AFW
Atlantic Family Wealth Coral Gables, Florida $156M AUM 21.68% 1-Year Est. Return
ADBIC
A.D. Beadell Investment Counsel Mequon, Wisconsin $156M AUM 29.03% 1-Year Est. Return
HSM
H Squared Management New York $156M AUM
FWM
FMA Wealth Management Duxbury, Massachusetts $156M AUM 15.22% 1-Year Est. Return
PIA
Polaris Investment Advisors Framingham, Massachusetts $156M AUM
CCP
Cyrus Capital Partners New York $156M AUM 81.61% 1-Year Est. Return

Bayesian Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Bayesian Capital Management held 1,060 positions worth $817M, down 4.2% from $853M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Bayesian Capital Management withdrew a net $39.4M in Q4 2024, closing 413 positions and reducing 111 holdings. Its most notable exit was Netflix, an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in Amgen worth $11.2M.

  • Bayesian Capital Management's largest Q4 2024 buy was Amgen: 43,000 shares worth $11.2M.
  • Bayesian Capital Management added most to Nike in Q4 2024, an estimated $8.85M increase.
  • Bayesian Capital Management's biggest Q4 2024 reduction was Tesla, cutting an estimated $16.6M.
  • Bayesian Capital Management fully exited Netflix in Q4 2024, selling an estimated $17.9M.
  • Bayesian Capital Management's ten largest holdings make up 12% of its $817M portfolio in Q4 2024.
  • Bayesian Capital Management opened 418 new positions and closed 413 in Q4 2024.
  • Bayesian Capital Management's portfolio value fell 4.2% quarter-over-quarter to $817M.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.